•
Helixworks Technologies • 7m
From ₹51 Cr to ₹1,272 Cr in a year—this Indian biotech’s revenue chart is insane. 💰 Molbio is going public targeting ₹22,000–24,000 Cr valuation. IPO expected in November 2025, raising ₹2,200–2,400 Cr. 🔬 Their Truenat platform, is a battery-power
See More•
Faad Network • 10m
Started the business at 17 when his father died and built a 60,000 CR empire. 1. At just 17, after he passed away, Nirmal Minda had to join his father's (Shadilal Minda) automotive parts business, Minda Industries. It produced ammeters for vehicles
See MoreDownload the medial app to read full posts, comements and news.